In a regulatory filing, iBio (IBIO) disclosed that its director Antonio Parada bought 183.8K shares of common stock on January 10th in a total transaction size of $500K. Shares of iBio are up 11% afterhours at $2.75.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBIO:
- iBio closes private placement offering with board members, officers
- iBio Advances Antibody Development for Obesity Treatment
- iBio, AstralBio announce development of antibody inhibiting Activin E
- iBio Expands Pipeline with New Antibody Agreement
- iBio expands cardiometabolic, obesity treatment development program